Literature DB >> 8282965

Insulin-like growth factor I values in patients on maintenance hemodialysis: relationship to growth hormone and albumin levels.

A Caufriez1, D Abramowicz, J L Vanherweghem, G Copinschi.   

Abstract

Twenty-seven uremic patients (blood urea: 58.2 +/- 2.2 mmol/l; blood creatinine: 1,069 +/- 53 mumol/l; mean +/- SE) on maintenance dialysis were investigated immediately before and after a dialysis session. Control data were obtained from 30 normal volunteers. Before dialysis, circulating levels of insulin-like growth factor I (IGF-I) were similar in anuric and nonanuric patients, averaging 305 +/- 24 micrograms/l, a value not different from that observed in normal controls (262 +/- 16 micrograms/l). IGF-I levels were not modified by dialysis. In contrast, GH values were significantly higher in uremic patients (3.6 +/- 0.6 microgram/l) than in normal controls (2.5 +/- 0.5 microgram/l) and decreased significantly after the dialysis session (0.8 +/- 0.1 microgram/l). IGF-I values were positively correlated with GH and albumin, but not with the various parameters of renal insufficiency, suggesting that in chronic renal failure, synthesis of IGF-I appears to be regulated, as in normal subjects, by growth hormone and nutritional status.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282965     DOI: 10.1007/BF03348913

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Serum somatomedin A in chronic renal failure.

Authors:  K Takano; K Hall; K W Kastrup; N Hizuka; K Shizume; K Kawai; M Akimoto; T Takuma; N Sugino
Journal:  J Clin Endocrinol Metab       Date:  1979-03       Impact factor: 5.958

2.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone.

Authors:  E Van Cauter; A Caufriez; M Kerkhofs; A Van Onderbergen; M O Thorner; G Copinschi
Journal:  J Clin Endocrinol Metab       Date:  1992-06       Impact factor: 5.958

Review 4.  The growth hormone-insulin-like growth factor axis in kidney.

Authors:  M R Hammerman
Journal:  Am J Physiol       Date:  1989-10

5.  Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia.

Authors:  W F Blum; M B Ranke; K Kietzmann; B Tönshoff; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

6.  Somatomedin inhibitor in uremia.

Authors:  L S Phillips; A C Fusco; T G Unterman; F del Greco
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

7.  IGF-I, a marker of undernutrition in hemodialysis patients.

Authors:  V Jacob; J E Le Carpentier; S Salzano; V Naylor; G Wild; C B Brown; A M el Nahas
Journal:  Am J Clin Nutr       Date:  1990-07       Impact factor: 7.045

8.  Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure.

Authors:  R C Baxter; A S Brown; J R Turtle
Journal:  Clin Chem       Date:  1982-03       Impact factor: 8.327

9.  Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function.

Authors:  L S Phillips; J D Kopple
Journal:  Metabolism       Date:  1981-11       Impact factor: 8.694

10.  Serum immunoreactive somatomedin-C is elevated late in pregnancy.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; S Handwerger
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

View more
  2 in total

1.  Acromegaly and end-stage renal disease: a diagnostic challenge.

Authors:  K Müssig; B Gallwitz; M B Ranke; M Horger; H U Häring; H J Quabbe
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

2.  A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients.

Authors:  Erik Nilsson; Juan Jesus Carrero; Olof Heimbürger; Olof Hellberg; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin Kidney J       Date:  2015-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.